Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis A virus replication: an intermediate in the uncoating process.

N E Bishop1

  • 1Hepatitis Research Unit, Macfarlane Burnet Centre for Medical Research, Fairfield, Vict., Australia.

Intervirology
|April 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A model of uniaxial implant seating by impaction.

Medical engineering & physics·2021
Same author

Maximizing the fixation strength of modular components by impaction without tissue damage.

Bone & joint research·2018
Same author

Factors influencing taper failure of modular revision hip stems.

Medical engineering & physics·2018
Same author

The relation between titanium taper corrosion and cobalt-chromium bearing wear in large-head metal-on-metal total hip prostheses: a retrieval study.

The Journal of bone and joint surgery. American volume·2014
Same author

Increase in facet joint loading after nucleotomy in the human lumbar spine.

Journal of biomechanics·2014
Same author

The effect of nucleotomy on facet joint loading in the porcine lumbar spine.

Computer methods in biomechanics and biomedical engineering·2013
Same journal

Formulated curcumin exerts potent anti-influenza activity by inhibition of Akt activation and viral genome replication.

Intervirology·2026
Same journal

Isolation of a Variant of the Felid Herpesvirus 1-Live Attenuated Vaccine Strain F2 from Unvaccinated Cats.

Intervirology·2026
Same journal

Antiviral activity of the chemokine CXCL10 against West Nile virus.

Intervirology·2025
Same journal

Serological Evidence of Bluetongue Virus Serotypes Circulating in Pakistan.

Intervirology·2025
Same journal

Expression of Concern.

Intervirology·2025
Same journal

Genetic and Antigenic Variability in VP4 and VP7 of Group A Human Rotavirus in Yunnan, China, from 2015 to 2020.

Intervirology·2025
See all related articles

Early in cell infection, non-infectious hepatitis A virus (HAV) particles containing VP2 form. These dense, RNase-sensitive particles appear as mature virions decrease, suggesting a role in the HAV uncoating process.

Area of Science:

  • Virology
  • Cell Biology
  • Molecular Biology

Background:

  • Hepatitis A virus (HAV) is a significant human pathogen.
  • Understanding HAV entry and uncoating is crucial for developing antiviral strategies.
  • Previous studies on picornavirus uncoating intermediates provide a comparative framework.

Purpose of the Study:

  • To characterize early-stage, non-infectious particles formed after HAV infection.
  • To investigate the kinetics and properties of these dense HAV particles.
  • To determine if these particles represent uncoating intermediates.

Main Methods:

  • Cell culture infection with HAV.
  • Isolation and characterization of dense HAV particles using CsCl density gradients.
  • RNA dot blot hybridization to quantify mature input virions.

Related Experiment Videos

  • Analysis of sedimentation coefficients.

    • Main Results:

    • Dense, RNase-sensitive, VP2-containing, non-infectious HAV particles are formed early post-infection.
    • Particle formation kinetics correlate with HAV uncoating.
    • A decrease in mature input virions was observed concurrently with dense particle formation.
    • Dense HAV particles exhibited unchanged sedimentation coefficients.

    Conclusions:

    • Early-forming dense HAV particles are likely intermediates in the viral uncoating process.
    • These particles are distinct from previously described 'A particles' or 'infectosomes' due to the unknown fate of VP4.